In just two months, Signatur Biosciences has clinically proven their technology, secured 6+ LOIs, and established partnerships with key industry players. They have raised $935k in the current round from investors including Amar Shah, a unicorn founder.
Organizations Involved
Y Combinator, Paradise Genomics, Biomedica, Imperial College London, Biotechne, AstraZeneca, Roche, Biocartis, Visby Medical, Sherlock Biosciences
Founders
Celestin de Wergifosse, John Goertz
Company Description
Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients.